upper stomach pain glp-1 Your guide to side effects Common GLP-1 Weight-loss Side Effects

257 Disruption of the colonic barrier is the most common pathological change in animal models of UC, and studies have shown that the SGLT2 inhibitor empagliflozin can significantly increase the expression of SIRT-1, suppress the levels of PI3K and AKT, and increase the levels of tight junction proteins (claudin-1 and occludin), thereby improving the integrity of the colonic barrier

Funding The author(s) declare that no financial support was received for the research, and/or publication of this article

These typically include nausea, vomiting, diarrhea, and stomach pain

Reduced kidney function, irregular meal patterns, and polypharmacy all increase the danger

He is an Assistant Professor, North Ontario School of Medicine, Lakehead University, and Chief of Dentistry, Thunder Bay Regional Health Sciences Center

doi: 10.1016/S2213-8587(18)30303-6